Management of Diabetic Foot Infections Using Phage Products: Unveiling TP-102 Phase IIb Study
Time: 11:30 am
day: Day One
Details:
- Articulating regulatory challenges in phage development to enable treatment of human disease
- Showcasing design of clinical trial protocol for safe and effective Phase IIb phage product
- Highlighting critical findings of phage therapy to treat diabetic foot infections from preliminary results
